Director/PDMR Shareholding

Balfour Beatty PLC
18 September 2024
 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMRs") AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

Balfour Beatty plc (the "Company") has been notified of the following purchase of Ordinary shares in the Company by Susan MacLeod, who is a Person Closely Associated ('PCA') with Robert MacLeod, Non Executive Director, on 17 September 2024:

 

Name of Director / PDMR

Number of Shares purchased

 

Susan MacLeod, PCA with Robert MacLeod

 

17,674

 

 

 

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.

 

Contact and telephone number for queries / Duly authorised officer of issuer responsible for making notification:

 

Tracey Wood, Group General Counsel and Company Secretary, 020 7216 6800

 



a)

Name

Susan MacLeod

2

Reason for the notification

a)

Position/status

PCA with Robert MacLeod, Non-Executive Director

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Balfour Beatty plc

b)

LEI

CT4UIJ3TUKGYYHMENQ17

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 50p each

 

 

GB0000961622

b)

Nature of the transaction

Purchase of shares.

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£4.2215

17,674

d)

Aggregated information

- Aggregated volume

- Price

n/a

e)

Date of the transaction

17 September 2024

f)

Place of the transaction

London Stock Exchange (XLON)

 

Balfour Beatty plc's Legal Entity Identifier is CT4UIJ3TUKGYYHMENQ17.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings